Insider · CIK 0001410291
Lori Freedman
Files at ORGO (Organogenesis Holdings Inc.). First filing Jun 6, 2025, latest Jun 6, 2025.
Lori Freedman files SEC Form 4 as officer at ORGO (Organogenesis Holdings Inc.). Since Jun 6, 2025, Lori Freedman has reported 1 open-market buy worth $725k and 0 open-market sells worth $0, the latest filed on Jun 6, 2025.
A track record needs three past buys with six months of prices behind them; Lori Freedman has 0, so none is measured yet.
The newest scored trade: bought $725k of ORGO on Jun 4, 2025, filed Jun 6, 2025, scored 50 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ORGO: Organogenesis Holdings Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | ORGObuy Organogenesis Holdings Inc. | $725k 252,264 shares | +42% | +12% from low-54% from high |
Transactions
Every row this insider has filed, 19 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | ORGO Organogenesis Holdings Inc. | AGrant or award Class A Common Stock | +43,212 | $0.00 | $0 | 1,038,054 | Mar 3, 2026 |
| Feb 18, 2026 | ORGO Organogenesis Holdings Inc. | FTax withholding Class A Common Stock | -14,411 | $3.84 | $55k | 1,023,643 | Mar 3, 2026 |
| Feb 18, 2026 | ORGO Organogenesis Holdings Inc. | AGrant or award Class A Common Stock | +203,125 | $0.00 | $0 | 994,842 | Feb 20, 2026 |
| Feb 18, 2026 | ORGO Organogenesis Holdings Inc. | AGrant or award Class A Common Stock | +42,780 | $0.00 | $0 | 1,037,622 | Feb 20, 2026 |
| Feb 18, 2026 | ORGO Organogenesis Holdings Inc. | FTax withholding Class A Common Stock | -14,267 | $3.84 | $55k | 1,023,355 | Feb 20, 2026 |
| Feb 18, 2026 | ORGO Organogenesis Holdings Inc. | AGrant or award Stock Option (Right to Buy)derivative | +115,812 | $0.00 | $0 | 115,812 | Feb 20, 2026 |
| Feb 15, 2026 | ORGO Organogenesis Holdings Inc. | FTax withholding Class A Common Stock | -4,043 | $3.73 | $15k | 842,416 | Feb 18, 2026 |
| Feb 15, 2026 | ORGO Organogenesis Holdings Inc. | FTax withholding Class A Common Stock | -24,428 | $3.73 | $91k | 817,988 | Feb 18, 2026 |
| Feb 15, 2026 | ORGO Organogenesis Holdings Inc. | FTax withholding Class A Common Stock | -12,761 | $3.73 | $48k | 805,227 | Feb 18, 2026 |
| Feb 15, 2026 | ORGO Organogenesis Holdings Inc. | FTax withholding Class A Common Stock | -13,510 | $3.73 | $50k | 791,717 | Feb 18, 2026 |
| Jun 4, 2025 | ORGO Organogenesis Holdings Inc. | POpen-market purchase Class A Common Stock | +100,863 | $2.82 | $285k | 695,058 | Jun 6, 2025 |
| Jun 5, 2025 | ORGO Organogenesis Holdings Inc. | POpen-market purchase Class A Common Stock | +142,379 | $2.91 | $414k | 837,437 | Jun 6, 2025 |
| Jun 6, 2025 | ORGO Organogenesis Holdings Inc. | POpen-market purchase Class A Common Stock | +9,022 | $2.99 | $27k | 846,459 | Jun 6, 2025 |
| Feb 19, 2025 | ORGO Organogenesis Holdings Inc. | AGrant or award Class A Common Stock | +162,047 | $0.00 | $0 | 594,195 | Feb 21, 2025 |
| Feb 19, 2025 | ORGO Organogenesis Holdings Inc. | AGrant or award Stock Option (Right to Buy)derivative | +167,625 | $0.00 | $0 | 167,625 | Feb 21, 2025 |
| Feb 15, 2025 | ORGO Organogenesis Holdings Inc. | FTax withholding Class A Common Stock | -11,230 | $3.70 | $42k | 458,042 | Feb 19, 2025 |
| Feb 15, 2025 | ORGO Organogenesis Holdings Inc. | FTax withholding Class A Common Stock | -22,178 | $3.70 | $82k | 435,864 | Feb 19, 2025 |
| Feb 15, 2025 | ORGO Organogenesis Holdings Inc. | FTax withholding Class A Common Stock | -3,070 | $3.70 | $11k | 432,794 | Feb 19, 2025 |
| Feb 16, 2025 | ORGO Organogenesis Holdings Inc. | FTax withholding Class A Common Stock | -646 | $3.70 | $2,390 | 432,148 | Feb 19, 2025 |
Questions about Lori Freedman
Answered from the filings on this page, as of the latest one.
Is Lori Freedman buying or selling?
Not in the last 12 months. Lori Freedman's latest open-market trade on SEC Form 4 was bought $725k of ORGO on Jun 4, 2025.
How did Lori Freedman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lori Freedman has 0.
Where does Lori Freedman file Form 4?
Lori Freedman has filed Form 4 at ORGO (Organogenesis Holdings Inc.) as Chief Admin. and Legal Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.